Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-06

Clinical Trial Update: Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants [NA]

View source ↗

Summary

A completed clinical trial investigating the impact of omega-3 fatty acids on retinopathy of prematurity in newborn infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Retinopathy of Prematurity | NA | Status: COMPLETED